These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 15686532

  • 1. Cyclic enkephalin analogs containing various para-substituted phenylalanine derivatives in place of Tyr1 are potent opioid agonists.
    Weltrowska G, Lemieux C, Chung NN, Schiller PW.
    J Pept Res; 2005 Jan; 65(1):36-41. PubMed ID: 15686532
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S, Kezar HS, Carter RL, Saini SK, Rice KC, Wells JL, Davis P, Xu H, Dersch CM, Bilsky EJ, Porreca F, Rothman RB.
    J Med Chem; 1999 Sep 09; 42(18):3527-38. PubMed ID: 10479286
    [Abstract] [Full Text] [Related]

  • 3. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R, Wilkes BC, Chung NN, Lemieux C, Schiller PW.
    Int J Pept Protein Res; 1996 Nov 09; 48(5):411-9. PubMed ID: 8956074
    [Abstract] [Full Text] [Related]

  • 4. Opioid profiles of Cys2-containing enkephalin analogues.
    Pencheva N, Milanov P, Vezenkov L, Pajpanova T, Naydenova E.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):249-56. PubMed ID: 15364002
    [Abstract] [Full Text] [Related]

  • 5. A novel cyclic enkephalin analogue with potent opioid antagonist activity.
    Weltrowska G, Lu Y, Lemieux C, Chung NN, Schiller PW.
    Bioorg Med Chem Lett; 2004 Sep 20; 14(18):4731-3. PubMed ID: 15324897
    [Abstract] [Full Text] [Related]

  • 6. In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands.
    Kramer TH, Davis P, Hruby VJ, Burks TF, Porreca F.
    J Pharmacol Exp Ther; 1993 Aug 20; 266(2):577-84. PubMed ID: 8394911
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E, Tourwé D, Kertész I, Tóth G, Borsodi A, Benyhe S.
    Brain Res Bull; 2007 Sep 14; 74(1-3):119-29. PubMed ID: 17683797
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and biological activity profile of new analogues of the cyclic opioid peptide H-Tyr-c[D-Cys-Gly-Phe(pNO2)-D-Cys]-NH2 containing (S)-alpha-hydroxymethylcysteine in place of cysteine.
    Witkowska R, Chung NN, Schiller PW, Zabrocki J.
    J Pept Sci; 2005 Jun 14; 11(6):361-3. PubMed ID: 15635653
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cyclic enkephalin analogues with exceptional potency and selectivity for delta-opioid receptors.
    Hruby VJ, Bartosz-Bechowski H, Davis P, Slaninova J, Zalewska T, Stropova D, Porreca F, Yamamura HI.
    J Med Chem; 1997 Nov 21; 40(24):3957-62. PubMed ID: 9397176
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Structure-activity relationships of Leu-Enkephalin analog with (4-Carboxamido)phenylalanine substituted for tyrosine: a molecular dynamics study.
    Wang YC, Wu YC, Yeh CC, Hwang CC.
    Biopolymers; 2007 Jun 15; 86(3):231-9. PubMed ID: 17377963
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Conformational studies of stereoisomeric 14-membered cyclic enkephalin analogues containing 1-naphthylalanine at the fourth position: chirality effect of leucine at the fifth position on biological activity and receptor selectivity.
    Yamazaki T, Said-Nejad OE, Schiller PW, Goodman M.
    Biopolymers; 1991 Jun 15; 31(7):877-98. PubMed ID: 1655089
    [Abstract] [Full Text] [Related]

  • 18. The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists.
    Schiller PW, Weltrowska G, Berezowska I, Nguyen TM, Wilkes BC, Lemieux C, Chung NN.
    Biopolymers; 1999 Jun 15; 51(6):411-25. PubMed ID: 10797230
    [Abstract] [Full Text] [Related]

  • 19. Ring substituted and other conformationally constrained tyrosine analogues of [D-Pen2,D-Pen5]enkephalin with delta opioid receptor selectivity.
    Toth G, Russell KC, Landis G, Kramer TH, Fang L, Knapp R, Davis P, Burks TF, Yamamura HI, Hruby VJ.
    J Med Chem; 1992 Jun 26; 35(13):2384-91. PubMed ID: 1320122
    [Abstract] [Full Text] [Related]

  • 20. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N, Murakawa K, Takada K, Oi Y, Suzuki T, Nagase H, Cools AR, Koshikawa N.
    Neuroscience; 2005 Jun 26; 135(1):213-25. PubMed ID: 16111831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.